Identifying the concepts contained in outcome measures of clinical trials on depressive disorders using the international classification of functioning, disability and health as a reference

被引:46
作者
Brockow, TT
Wohlfahrt, K
Hillert, A
Geyh, S
Weigl, M
Franke, T
Resch, KL
Cieza, A
机构
[1] Univ Munich, Dept Phys Med & Rehabil, DE-81377 Munich, Germany
[2] Spa Med Res Inst, Bad Elster, Germany
[3] Ctr Behav Med, Prien Am Chiemsee, Germany
[4] Univ Munich, IMBK, WHO FIC Collaborating Ctr DIMDI, ICF Res Branch, Munich, Germany
关键词
depressive disorders; outcome assessment; systematic review; ICF;
D O I
10.1080/16501960410015380
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objectives: First, to systematically identify the concepts contained in outcome measures of trials on depressive disorders using the International Classification of Functioning, Disability and Health (ICF) as a reference. Secondly, to explore differences in the use of ICF categories across different intervention types. Thirdly, to examine which and how often health status measures have been applied in trials on depressive disorders. Methods: Randomized controlled trials between 1991 and 2000 were located in MEDLINE and selected according to predefined criteria. The outcome measures were extracted and the concepts contained in the outcome measures were linked to the ICF. Results: A random sample of 203 (50%) of 406 eligible studies were included. The 5 most used ICF categories (range 88-94%) were sleep functions (b134), emotional functions (b152), energy and drive functions (b130), thought functions (b160) and higher-level cognitive functions (b164), all belonging to the body functions component. The use of ICF categories did not vary across different intervention types. A total of 126 different health status measures were extracted. The Hamilton Rating Scale for Depression was the most used health status measure applied in 80% of the studies. Conclusion: Concepts about execution of tasks/actions, participation in life situations, and the influence of the environment were under-represented in the outcome assessment of trials on depressive disorders. These observations indicate that most trials were limited in their ability to assess more global individual outcomes.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 49 条
  • [1] EFFECTIVE TREATMENT OF POSTSTROKE DEPRESSION WITH THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR CITALOPRAM
    ANDERSEN, G
    VESTERGAARD, K
    LAURITZEN, L
    [J]. STROKE, 1994, 25 (06) : 1099 - 1104
  • [2] [Anonymous], ASSESSMENT DEPRESSIO
  • [3] Bech P, 1981, Acta Psychiatr Scand Suppl, V295, P1
  • [4] AN INVENTORY FOR MEASURING DEPRESSION
    BECK, AT
    ERBAUGH, J
    WARD, CH
    MOCK, J
    MENDELSOHN, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) : 561 - &
  • [5] COPING BEHAVIOR IN DEPRESSION - REPORT ON A NEW SCALE
    BECKHAM, EE
    ADAMS, RL
    [J]. BEHAVIOUR RESEARCH AND THERAPY, 1984, 22 (01) : 71 - 75
  • [6] The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder
    Bouffard, R
    Hechtman, L
    Minde, K
    Iaboni-Kassab, F
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08): : 546 - 554
  • [7] Brown C, 1996, AM J PSYCHIAT, V153, P1293
  • [8] THE CARROLL RATING-SCALE FOR DEPRESSION .1. DEVELOPMENT, RELIABILITY AND VALIDATION
    CARROLL, BJ
    FEINBERG, M
    SMOUSE, PE
    RAWSON, SG
    GREDEN, JF
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1981, 138 (MAR) : 194 - 200
  • [9] Linking health-status measurements to the international classification of functioning, disability and health
    Cieza, A
    Brockow, T
    Ewert, T
    Amman, E
    Kollerits, B
    Chatterji, S
    Üstün, TB
    Stucki, G
    [J]. JOURNAL OF REHABILITATION MEDICINE, 2002, 34 (05) : 205 - 210
  • [10] Cloninger C.R., 1987, TRIDIMENSIONAL PERSO